# Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy

> **NCT02597855** · — · UNKNOWN · sponsor: **Yeungnam University College of Medicine** · enrollment: 29 (actual)

## Conditions studied

- Polypoidal Choroidal Vasculopathy

## Interventions

- **DRUG:** Aflibercept
- **DRUG:** Indocyanine green angiography (intraveonus indocyanine green dye)

## Key facts

- **NCT ID:** NCT02597855
- **Lead sponsor:** Yeungnam University College of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-08
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2016-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02597855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02597855, "Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02597855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*